Latest breakthroughs in the treatment of breast cancerBy 2025, the domain of advanced breast cancer treatment is swiftly transforming, providing renewed optimism to patients globally. Recent advanceme...
IMPower133 study The IMpower133 study has brought significant advancements in the treatment of advanced-stage small-cell lung cancer (ES-SCLC). By combining atezolizumab, a type of immunotherapy, wit...
CAR T Cell therapy for gastric cancer The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting introduced an important new cancer treatment: Satricabtagene autoleucel (satri-cel), a CAR T...
Lung Cancer Treatment at Shanghai Pulmonary Hospital - A patient story In April 2025, Shanghai Pulmonary Hospital welcomed a special patient, Ms. Dietrich from the United States. In 2024, doctors dia...
Professor Jiang Tao's Team from Beijing Tiantan Hospital Neurosurgery Leads the Establishment of China's First Advanced Innovative Treatment Clinic for Gliomas CureBreaking Through Treatment Dilemmas ...
Brain GliomaBrain glioma is one of the most common malignant tumors of the central nervous system. Despite numerous challenges in the treatment field, scientific advancements recently have brought new...
Advanced Pancreatic Cancer Treatment in China"We want to uncover the ultimate laws governing the true occurrence and development of pancreatic cancer and completely transform the treatment outcomes fo...
On May 15, 2025, the Food and Drug Administration sanctioned retifanlimab-dlwr (Zynyz, Incyte Corporation) in conjunction with carboplatin and paclitaxel for the initial treatment of people with inope...
On May 14, 2025, the Food and Drug Administration sanctioned belzutifan (Welireg, Merck & Co., Inc.) for adult and pediatric patients aged 12 and older diagnosed with locally advanced, unresectabl...
On May 8, 2025, the Food and Drug Administration approved the use of avutometinib and defactinib (Avmapki Fakzynja Co-pack, Verastem, Inc.) for adults with KRAS-mutated recurrent low-grade serous ovar...